KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

Lazzari, Paolo; Spiga, Marco; Sani, Monica; Zanda, Matteo; Fleming, Ian N

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

Files

HP_132832_kemtub012_ni2_a_novel_potent_tubulysin_analogue_that_select_052317.pdf (1.56 MB)

Date

2017-05-23

Authors

Citation

Lazzari, P, Spiga, M, Sani, M, Zanda, M & Fleming, I N 2017, 'KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation', Hypoxia, vol. 5, pp. 45-59. https://doi.org/10.2147/HP.S132832